Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T-cell Lymphoma (PTCL and CTCL)”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Early research (Phase 1)Looking for participantsNCT07195916
What this trial is testing

Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Solid TumorsHematologic Malignancies
Incyte Corporation 280
Early research (Phase 1)Study completedNCT02689453
What this trial is testing

Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)

Who this might be right for
T-Cell Lymphoma RelapsedAdult T-Cell Leukemia (ATL)Peripheral T-Cell Lymphoma (PTCL)+2 more
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Ended earlyNCT04362007
What this trial is testing

A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma

Who this might be right for
Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
Otsuka Pharmaceutical Co., Ltd. 8
Testing effectiveness (Phase 2)Study completedNCT03192202
What this trial is testing

AFM13 in Relapsed/Refractory Cutaneous Lymphomas

Who this might be right for
Lymphoma, T-Cell, Cutaneous
Ahmed Sawas 18
Testing effectiveness (Phase 2)Ended earlyNCT00274651
What this trial is testing

A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas

Who this might be right for
Cutaneous T-Cell LymphomaPeripheral T-Cell LymphomaNon-Hodgkin's Lymphoma
Valerio Therapeutics 53
Early research (Phase 1)Active Not RecruitingNCT02732275
What this trial is testing

DS-3201b in Participants With Lymphomas

Who this might be right for
Lymphoma, MalignantNon-hodgkin Lymphoma
Daiichi Sankyo Co., Ltd. 100
Early research (Phase 1)Looking for participantsNCT04234048
What this trial is testing

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Who this might be right for
T-cell LymphomaCutaneous/Peripheral T-Cell LymphomaPeripheral T-cell Lymphoma+8 more
SciTech Development, Inc. 46
Early research (Phase 1)Active Not RecruitingNCT04072458
What this trial is testing

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

Who this might be right for
Mantle Cell LymphomaPeripheral T-cell Lymphoma (PTCL)Cutaneous T-cell Lymphoma (CTCL)+7 more
Bio-Path Holdings, Inc. 30
Early research (Phase 1)Ended earlyNCT03601819
What this trial is testing

Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders

Who this might be right for
Lymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralChronic Lymphocytic Leukemia+4 more
University of Michigan Rogel Cancer Center 4
Testing effectiveness (Phase 2)Temporarily pausedNCT05138458
What this trial is testing

MT-101 in Subjects With CD5+ Relapsed/Refractory TCL

Who this might be right for
Lymphoma, T-Cell, PeripheralLymphoma, T-Cell, CutaneousMycosis Fungoides+2 more
Myeloid Therapeutics 40
Testing effectiveness (Phase 2)Looking for participantsNCT06810778
What this trial is testing

Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
T-cell-prolymphocytic LeukemiaCutaneous T-Cell Lymphoma Refractory
Jonsson Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT07022964
What this trial is testing

CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas

Who this might be right for
T-Cell Non-Hodgkin LymphomaT-cell Lymphoma (PTCL and CTCL)
Beijing GoBroad Hospital 36
Early research (Phase 1)Looking for participantsNCT05079282
What this trial is testing

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

Who this might be right for
Relapsed or Refractory T Cell Lymphoma
Ono Pharmaceutical Co., Ltd. 217
Early research (Phase 1)Study completedNCT02017613
What this trial is testing

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in Hematological Malignancies

Who this might be right for
Lymphoma, B-CellT-Cell Lymphoma
Rhizen Pharmaceuticals SA 35
Early research (Phase 1)Study completedNCT02567656
What this trial is testing

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

Who this might be right for
Lymphoma, T-Cell, PeripheralLymphoma, T-Cell, Cutaneous
Rhizen Pharmaceuticals SA 58
Testing effectiveness (Phase 2)Study completedNCT00888927
What this trial is testing

Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-Cell Lymphoma
Kyowa Kirin Co., Ltd. 42
Early research (Phase 1)Active Not RecruitingNCT02520791
What this trial is testing

Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma

Who this might be right for
Advanced Primary Cutaneous T-Cell Non-Hodgkin LymphomaRecurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-TypeRecurrent Grade 1 Follicular Lymphoma+16 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02512497
What this trial is testing

Romidepsin Maintenance After Allogeneic Stem Cell Transplantation

Who this might be right for
Cutaneous T-cell LymphomaT-Prolymphocytic LeukemiaT-Large Granulocytic Leukemia+2 more
Ohio State University Comprehensive Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT01994382
What this trial is testing

Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL

Who this might be right for
Follicular Lymphoma (FL/Indolent NHL)Aggressive NHL (a NHL)Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)+2 more
Alexion Pharmaceuticals, Inc. 260
Testing effectiveness (Phase 2)Looking for participantsNCT05475925
What this trial is testing

DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Who this might be right for
LGLL - Large Granular Lymphocytic LeukemiaPrimary Cutaneous Gamma-Delta T-Cell LymphomaPrimary Cutaneous CD8+ Aggressive Epidermotropic T-Cell Lymphoma+10 more
Dren Bio 200
Load More Results
21